<DOC>
	<DOCNO>NCT02026960</DOCNO>
	<brief_summary>The primary objective evaluate method AGS-003 production surgical ( stage I ) metastatic biopsy ( stage II ) Renal Cell Carcinoma ( RCC ) small subset GU cancer ( expansion cohort ) specimens use core needle biopsy subject RCC GU cancer . Specifically , study evaluate feasibility RNA amplification total tumor RNA isolate tissue obtain core needle tumor biopsy .</brief_summary>
	<brief_title>RNA Extraction Amplification From Biopsy Specimens Subjects With Metastatic Renal Cell Carcinoma ( AGS-NTS-017 )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Urogenital Neoplasms</mesh_term>
	<criteria>A subject metastatic RCC , opinion treat physician , potential candidate inclusion study follow criterion apply : 1 . 18 year age old . 2 . Suspected RCC , opinion investigator 3 . Availability either : Nephrectomy surgically remove tissue ( Stage I ) ; , Metastatic RCC biopsy tissue utilize needle core biopsy procedure ( Stage II ) . 4 . â‰¥5 biopsy specimen available BRPC . Subjects surgical procedure ( i.e . metastasectomy , nephrectomy ) core biopsy obtain surgical specimen , per BRPC protocol . 5 . Not currently treat systemic therapy . 1 . Tumor tissue commit use inadequate RNA analysis . 2 . Insufficient tissue collect BRPC . Expansion Cohort Genitourinary Cancers : 1 . 18 year age old 2 . Suspected bladder , prostate , testicular cancer , opinion investigator . 3 . Availability surgically remove tissue biopsy tissue . 4 . At least 2 biopsy specimen available BRPC 5 . Not currently treat systemic therapy . 1 . Tumor tissue commit use inadequate RNA analysis . 2 . Insufficient tissue collect BRPC .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>